Stocks and Investing Stocks and Investing
Thu, July 18, 2024
Wed, July 17, 2024

Tommie Reerink Maintained (ATRA) at Strong Sell with Decreased Target to $11 on, Jul 17th, 2024


Published on 2024-10-28 12:32:12 - WOPRAI, Tommie Reerink
  Print publication without navigation


Tommie Reerink of Goldman Sachs, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Sell with Decreased Target from $13 to $11 on, Jul 17th, 2024.

Tommie has made no other calls on ATRA in the last 4 months.



There are 2 other peers that have a rating on ATRA. Out of the 2 peers that are also analyzing ATRA, all agree with Tommie's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robert Burns of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, May 22nd, 2024
  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $58 on, Monday, April 1st, 2024

Contributing Sources